473 related articles for article (PubMed ID: 30871555)
1. LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway.
Li H; Zhao Q; Chang L; Wei C; Bei H; Yin Y; Chen M; Wang H; Liang J; Wu Y
Lipids Health Dis; 2019 Mar; 18(1):62. PubMed ID: 30871555
[TBL] [Abstract][Full Text] [Related]
2. lncRNA ZFAS1 promotes ox-LDL induced EndMT through miR-150-5p/Notch3 signaling axis.
Yin Q; He M; Huang L; Zhang X; Zhan J; Hu J
Microvasc Res; 2021 Mar; 134():104118. PubMed ID: 33278458
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of LINC00657 inhibits ox-LDL-induced endothelial cell injury by regulating miR-30c-5p/Wnt7b/β-catenin.
Wu H; Liu T; Hou H
Mol Cell Biochem; 2020 Sep; 472(1-2):145-155. PubMed ID: 32577947
[TBL] [Abstract][Full Text] [Related]
4. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
J Biomed Sci; 2018 Feb; 25(1):11. PubMed ID: 29415742
[TBL] [Abstract][Full Text] [Related]
5. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.
Wang K; Yang C; Shi J; Gao T
Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709
[TBL] [Abstract][Full Text] [Related]
6. MiR-200c-3p promotes ox-LDL-induced endothelial to mesenchymal transition in human umbilical vein endothelial cells through SMAD7/YAP pathway.
Mao Y; Jiang L
J Physiol Sci; 2021 Sep; 71(1):30. PubMed ID: 34525946
[TBL] [Abstract][Full Text] [Related]
7. Loss of exosomal MALAT1 from ox-LDL-treated vascular endothelial cells induces maturation of dendritic cells in atherosclerosis development.
Li H; Zhu X; Hu L; Li Q; Ma J; Yan J
Cell Cycle; 2019 Sep; 18(18):2255-2267. PubMed ID: 31305205
[No Abstract] [Full Text] [Related]
8. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway.
Diao H; Cheng J; Huang X; Huang B; Shao X; Zhao J; Lan D; Zhu Q; Yan M; Zhang Y; Rong X; Guo J
J Ethnopharmacol; 2022 Jul; 293():115261. PubMed ID: 35447198
[TBL] [Abstract][Full Text] [Related]
9. The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway.
Li S; Sun Y; Zhong L; Xiao Z; Yang M; Chen M; Wang C; Xie X; Chen X
Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1175-1187. PubMed ID: 30314869
[TBL] [Abstract][Full Text] [Related]
10. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor alleviates endothelial injury by inhibiting Wnt/β-catenin pathway.
Ma S; Yao S; Tian H; Jiao P; Yang N; Zhu P; Qin S
Lipids Health Dis; 2017 Feb; 16(1):31. PubMed ID: 28173817
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MALAT1 promotes oxidized low-density lipoprotein-induced autophagy in HUVECs by inhibiting the PI3K/AKT pathway.
Li S; Pan X; Yang S; Ma A; Yin S; Dong Y; Pei H; Bi X; Li W
J Cell Biochem; 2019 Mar; 120(3):4092-4101. PubMed ID: 30485490
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis.
Bian W; Jing X; Yang Z; Shi Z; Chen R; Xu A; Wang N; Jiang J; Yang C; Zhang D; Li L; Wang H; Wang J; Sun Y; Zhang C
Aging (Albany NY); 2020 Apr; 12(7):6385-6400. PubMed ID: 32267831
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MALAT1 Promotes STAT3-Mediated Endothelial Inflammation by Counteracting the Function of miR-590.
Zhou Q; Run Q; Li CY; Xiong XY; Wu XL
Cytogenet Genome Res; 2020; 160(10):565-578. PubMed ID: 33022677
[TBL] [Abstract][Full Text] [Related]
15. lncRNA MALAT1 mediated high glucose-induced HK-2 cell epithelial-to-mesenchymal transition and injury.
Zhang J; Jiang T; Liang X; Shu S; Xiang X; Zhang W; Guo T; Xie W; Deng W; Tang X
J Physiol Biochem; 2019 Nov; 75(4):443-452. PubMed ID: 31388927
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z
J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861
[TBL] [Abstract][Full Text] [Related]
17. The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs.
Di M; Zhang Y; Zeng R; Liu X; Chen W; Zhang M; Zhang C; Li M; Zhang M
Int J Biol Sci; 2021; 17(15):4122-4139. PubMed ID: 34803487
[No Abstract] [Full Text] [Related]
18. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
Yang L; Gao C
Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
[TBL] [Abstract][Full Text] [Related]
19. MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway.
Liang J; Liang L; Ouyang K; Li Z; Yi X
J Oral Pathol Med; 2017 Feb; 46(2):98-105. PubMed ID: 27353727
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway.
Guo J; Li J; Zhang J; Guo X; Liu H; Li P; Zhang Y; Lin C; Fan Z
Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3508-3521. PubMed ID: 34627697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
